Prevention of neurodegenerative damage to the brain in rats in experimental Alzheimer's disease by adaptation to hypoxia

Neuroscience and Behavioral Physiology

Volumn 40, Issue 7, 2010, Pages 737-743

  Manukhina, E B ^a   Goryacheva, A V ^a   Barskov, I V ^b   Viktorov, I V ^b   Guseva, A A ^c   Pshennikova, M G ^a   Khomenko, I P ^a   Mashina, S Yu ^a   Pokidyshev, D A ^a   Malyshev, I Yu ^a  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c NONE

Author keywords

adaptation to hypoxia; Alzheimer's disease; beta amyloid; brain neurons; nitric oxide; oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; LIPID; NITRATE; NITRIC OXIDE; NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADAPTATION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN LEVEL; BRAIN PROTECTION; BRAIN TISSUE; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; HISTOPATHOLOGY; LIPID PEROXIDATION; MAGNOCELLULAR NUCLEUS; MALE; MEMORY; NISSL STAINING; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRESSURE CHAMBER; RAT; SPECTROPHOTOMETRY;

ADAPTATION, PHYSIOLOGICAL; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANOXIA; LIPID PEROXIDATION; MEMORY; NERVE DEGENERATION; NEURONS; NITRIC OXIDE; NITRITES; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 77955550654     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-010-9320-6     Document Type: Article

References (44)

1. S. O. Bachurin, "Medical chemistry of the targeted search for agents for the treatment and prevention of neurodegenerative diseases using Alzheimer's disease as an example," in: Neurodegenerative Diseases and Aging [in Russian], I. A. Zavalishin, N. N. Yakhno, and S. I. Gavrilova (eds.), Moscow (2001), pp. 399-454.
2. AF Vanin 1998 Dinitrosyl complexes of iron and S-nitrosothiols - two possible forms of stabilization and transport of nitric oxide in biological systems Biokhimiya 63 7 924 938
3. SA Elchaninova NA Korenyak IV Smagina LE Pinegin B Ya 2002 Varshavskii, "Discontinuous hypoxia in the treatment of chronic cerebral ischemia, Zh. Nevrol. Psikhiat. im. S. S. Korsakova 102 29 32
4. AL Krushinskii VP Reutov VS Kuzenkov EG Sorokina VB Koshelev OE Fadyukova LM Baider ZV Kuropteva TT Zhumabaeva LKh Komissarova TV Ryasina NS Kositsyn VG Pinelis 2007 Nitric oxide is involved in the mechanisms of short-term adaptation to hypoxia and protective actions during the development of stress lesions in Krushinskii-Molodkina rats Izv. Ros. Akad. Nauk. Ser. Biol. 34 3 329 335
5. VI Kulinskii LN Minakina TV Gavrilina 2002 Neuroprotective effects of hypoxic preconditioning: the phenomenon and its mechanisms Byull. Eksperim. Biol. Med. 133 2 237 239
6. EB Manukhina F Viegant VI Torshin AV Goryacheva IP Khomenko SV Kruglov SYu Mashina DA Pokidyshev EV Popova MG Pshennikova MA Vlasova OM Zelenina IYu Malyshev 2004 Potential non-medication-based approaches to Alzheimer's disease Izv. Ros. Akad. Nauk. Ser. Biol. 31 4 382 395
7. EB Manukhina IYu Malyshev 2000 The stress-limiting nitric oxide system Ros. Fiziol. Zh. im. I. M. Sechenova 86 10 1283 1292
8. EB Manukhina BV Smirin IYu Malyshev Zh-K Stokle B Muller AP Solodkov VI Shebeko AF Vanin 2002 Deposition of nitric oxide in the cardiovascular system Izv. Akad. Nauk. Ser. Biol. 29 5 585 596
9. SYu Mashina VV Aleksandrov AV Goryacheva MA Vlasova AF Vanin IYu Malyshev EB Manukhina 2006 Adaptation to hypoxia prevents impairments of cerebral circulation in neurodegenerative damage: the role of nitric oxide Byull. Eksperim. Biol. Med. 142 8 132 135
10. F. Z. Meerson, Adaptation Medicine: Mechanisms and Protective Effects of Adaptation, Hypoxia Medical Ltd., Moscow (1993).
11. FZ Meerson VG Pinelis VB Kosheleva LYu Golubeva TV Ryasina N Arsen'eva AL Krushinskii TP Storozhevykh 1993 Adaptation to periodic hypoxia restricts subdural hemorrhage in epileptiform convulsions in rats Byull. Eksperim. Biol. Med. 116 572 574
12. M. G. Pshennikova, E. V. Popkova, D. A. Pokidyshev, I. P. Khomenko, O. M. Zelenina, S. V. Kruglov, E. B. Manukhina, M. V. Shimkovich, A. V. Goryaeva, and I. Yu. Malyshev, "Effects of adaptation to hypoxia on resistance to neurodegenerative brain damage in rats of different genetic strains," Vestn. Ros. Akad. Med. Nauk., No. 2, 50-55 (2007).
13. MG Pshennikova EV Popkova IP Khomenko EB Manukhina AV Goryacheva SYu Mashina DA Pokidyshev IYu Malyshev 2005 Comparison of resistance to neurodegenerative brain damage in august rats and the Wistar population Byull. Eksperim. Biol. Med. 139 5 540 542 10.1007/s10517-005-0340-0 (Pubitemid 41258741)
14. JI Addae FF Youssef TW Stone 2003 Neuroprotective role of learning in dementia: a biological explanation J. Alzheimer's Dis. 5 91 104
15. RL Berghmans 2000 Anti-Alzheimer drugs: ethical aspects of research and practice Tijdschr. Gerontol. Geriatr. 31 100 106 10900662
16. M Bernaudin AS Nedelec D Divoux ET MacKenzie E Petit P Schumann-Bard 2002 Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain J. Cereb. Blood Flow Metab. 22 393 403 10.1097/00004647-200204000-00003 11919510
17. D Boyd-Kimball R Sultana HF Poon BC Lunn F Casamenti G Pepeu JB Klein DA Butterfield 2005 Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease Neurosci. 132 313 324 10.1016/j. neuroscience.2004.12.022 (Pubitemid 40417906)
18. H. Braak, U. Rüb, C. Schultz, and K. Del Tredici, "Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases," J. Alzheimer's Dis., 9, No. 3, Supplement, 35-44 (2006).
19. DA Butterfield 2002 Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review Free Radic. Res. 36 1307 1313 10.1080/1071576021000049890 12607822 (Pubitemid 35469517)
20. V Calabrese E Guagliano M Sapienza C Mancuso DA Butterfield AM Stella 2006 Redox regulation of cellular stress response in neurodegenerative disorders Ital. J. Biochem. 55 263 282 17274531
21. V Calabrese TE Bates AM Stella 2000 NO synthase and NOdependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance Neurochem. Res. 25 1315 1341 10.1023/A:1007604414773 11059804
22. CA Davies DM Mann PQ Sumpter PO Yates 1987 A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease J. Neurol. Sci. 78 151 164 10.1016/0022-510X(87)90057-8 3572454 (Pubitemid 17031709)
23. ST De Kosky SW Scheff 1990 Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann. Neurol. 27 457 464 10.1002/ana.410270502
24. H Fai Poon V Calabrese G Scapagnini DA Butterfield 2004 Free radicals: Key to brain aging and heme oxygenase as a cellular response to oxidative stress J. Gerontol. Series A: Biol. Sci. Med. Sci. 59 M478 M493
25. MR Farlow ML Miller V Pejovic 2008 Treatment options in Alzheimer's disease: maximizing benefit, managing expectations Dement. Geriatr. Cogn. Disord. 25 408 422 10.1159/000122962 18391487 Epub April 3 (Pubitemid 351630074)
26. RA Floyd 1999 Antioxidants, oxidative stress, and degenerative neurological disorders Proc. Soc. Exp. Biol. Med. 222 236 245 10.1046/j.1525-1373.1999.d01-140.x 10601882
27. N. V. Gulyaeva, M. V. Stepanichev, M. V. Onufriev, I. V. Sergeev, O. S. Mitrokhina, Yu. V. Moiseeva, and E. N. Tkatchouk, "Interval hypoxia training prevents oxidative stress in striatum and locomotor disturbances in a rat model of parkinsonism," in: Progress in Alzheimer's and Parkinson's Diseases, A. Fisher, I. Hahn, and M. Yoshida (eds.), Plenum Press (1998), pp. 717-723.
28. M. E. Jung, J. W. Simpkins, A. M. Wilson, H. F. Downey, and R. T. Mallet, "Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol withdrawn rats," J. Appl. Physiol. [Epub ahead of print, May 22, 2008].
29. U Keil A Bonert CA Marques I Scherping J Weyerman JB Strosznajder F Müller-Spahn C Haass C Czech L Pradier WE Müller A Eckert 2004 Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis J. Biol. Chem. 279 50310 50320 10.1074/jbc.M405600200 15371443 (Pubitemid 39577847)
30. DS Kim JY Kim YS Han 2007 Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult J. Atern. Complement. Med. 13 333 340 10.1089/acm.2006.6107 (Pubitemid 46676776)
31. AM Lin CF Chen LT Ho 2002 Neuroprotective effect of intermittent hypoxia on iron-induced oxidative injury in rat brain Exp. Neurol. 176 328 335 10.1006/exnr.2002.7938 12359174 (Pubitemid 35193349)
32. N Mahendra S Arkin 2003 Effects of four years of exercise, language, and social interventions on Alzheimer discourse J. Commun. Disord. 36 395 422 10.1016/S0021-9924(03)00048-0 12927946 (Pubitemid 36962909)
33. T Malinski 2007 Nitric oxide and nitroxidative stress in Alzheimer's disease J. Alzheimer's Dis. 11 207 218
34. SI Marklund NG Westman E Lundgren G Roos 1982 Copperand zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues Cancer Res. 42 1955 1961 7066906
35. PI Moreira MS Santos CR Oliveira JC Shenk A Nunomura MA Smith X Zhu G Perry 2008 Alzheimer disease and the role of free radicals in the pathogenesis of the disease CNS Neurol. Disord. Targets 7 3 10 10.2174/187152708783885156 (Pubitemid 351516211)
36. JA Neubauer 2001 Physiological and pathophysiological responses to intermittent hypoxia J. Appl. Hypoxia 90 1593 1599
37. H Ohkawa N Ohishi K Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 351 358 10.1016/0003-2697(79) 90738-3 36810 (Pubitemid 9194347)
38. GM Pasinetti Z Zhao W Qin L Ho Y Shrishailam D Macgrogan W Ressmann N Humala X Liu C Romero B Stetka L Chen H Ksiezak-Reding J Wang 2007 Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications Interdiscip. Top. Gerontol. 35 159 175 17063038
39. KN Prasad WC Cole KC Prasad 2002 Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment J. Am. Coll. Nutr. 21 506 522 12480796
40. DJ Selkoe 2002 Alzheimer's disease is a synaptic failure Science 298 789 791 10.1126/science.1074069 12399581 (Pubitemid 35231524)
41. GL Semenza 2004 O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1 J. Appl. Physiol. 96 1173 1177 10.1152/japplphysiol.00770.2003 14766767 (Pubitemid 38248698)
42. T Soucek R Cumming R Dargusch P Maher D Schubert 2003 The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide Neuron 39 43 56 10.1016/S0896-6273(03)00367-2 12848931 (Pubitemid 36830947)
43. PJ Whitehouse DL Price AW Clark JT Coyle MR De- Long 1981 Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis Ann. Neurol. 10 122 126 10.1002/ana.410100203 7283399 (Pubitemid 11053099)
44. MM Zaleska K Nagy RA Floyd 1989 Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes Neurochemistry 14 597 605 10.1007/BF00964867